-
Midecamycin in Antibacterial Assay Design
2026-09-01
Midecamycin is an acetoxy-substituted macrolide antibiotic suited to Gram-positive susceptibility testing, resistance profiling, and mechanism-oriented assay development. This guide translates published MIC workflows into practical preparation, optimization, and troubleshooting steps while defining where Gram-negative results and glycosylation studies require caution.
-
Itraconazole in Candida Biofilm Research
2026-08-31
Use Itraconazole as both a triazole antifungal agent and a mechanistic probe in Candida biofilm, resistance, and CYP3A4 interaction workflows. This guide connects practical assay design with PP2A–autophagy biology while clearly separating reference findings from proposed optimization conditions.
-
LGK-974: Translating Wnt Biology Into Strategy
2026-08-30
LGK-974 is a highly specific PORCN inhibitor that enables researchers to connect Wnt ligand secretion with pathway biomarkers, genetically informed cancer models, and translational decision-making. This thought-leadership perspective integrates mechanistic evidence, developmental biology, experimental design, and the limitations that must shape future Wnt-driven cancer research.
-
Homoharringtonine Workflows for Cancer & Antiviral Research
2026-08-29
Homoharringtonine is a cytotoxic alkaloid that connects ribosome-level translation control with practical leukemia and virus-replication assays. This guide translates its mechanism into dose-response, cell-cycle, and SARS-CoV-2 research workflows while emphasizing formulation, toxicity controls, and evidence-aware interpretation.
-
Calpain Inhibitor I, ALLN: Practical Guide
2026-08-29
Calpain Inhibitor I, ALLN (SKU A2602) supports controlled studies of calpain and cathepsin activity in apoptosis, inflammation, and ischemia-reperfusion workflows. It is water-insoluble and intended for research use only, so solvent matching, stock stability, and orthogonal controls are essential; the dossier does not establish a universal dosing or treatment protocol.
-
GTP Solution in Translational mRNA Therapy
2026-08-28
How high-quality GTP supports reproducible in vitro transcription and strengthens the translational path from localized p21 mRNA–LNP research to clinically actionable RNA therapeutics.
-
Merbromin Inhibits SARS-CoV-2 3CLpro
2026-08-28
Chen et al. identified merbromin as a selective, mixed-type inhibitor of the SARS-CoV-2 main protease 3CLpro through enzyme-based high-throughput screening, kinetic analysis, binding assays, and molecular docking. The study provides a mechanistic screening framework and a chemical scaffold for protease inhibitor development, while its in vitro scope defines important limits for translational interpretation.
-
Cy5.5 NHS Ester: NIR Biomolecule Labeling Workflow
2026-08-27
Build reliable amine-labeling workflows for proteins, peptides, and amino-modified oligonucleotides with a near-infrared readout suited to tissue studies. The article translates an aged osteoarthritis hydrogel study into practical decisions for tracking nanoparticle retention, cargo distribution, and in vivo fluorescence imaging.
-
Tin Mesoporphyrin IX: From HO Biology to Translation
2026-08-27
A translational framework for using Tin Mesoporphyrin IX (chloride) to separate heme oxygenase catalytic activity from HO-1 expression, with applications spanning heme catabolism, metabolic disease research, insulin resistance study design, and emerging antiviral hypotheses.
-
SIRT4, Glutamine Metabolism, and Liver Fibrosis
2026-08-26
The reference study identifies SIRT4-mediated control of glutamate dehydrogenase as a metabolic brake on hepatic stellate cell activation and liver fibrosis. By combining pharmacological inhibition of GDH with SIRT4 overexpression in cellular and animal experiments, the authors connect glutamine catabolism, α-ketoglutarate production, HSC proliferation, and fibrotic progression.
-
Azilsartan in RAS and Neuroinflammation Workflows
2026-08-26
Azilsartan (TAK-536) provides a selective AT1-receptor perturbation tool for separating renin–angiotensin signaling from broader anti-inflammatory effects. This guide translates a reactive astrocyte–microglia study into practical dosing, control, readout, and troubleshooting strategies.
-
G007-LK Tankyrase 1/2 Inhibitor Workflow
2026-08-25
Build a mechanism-first workflow around G007-LK for Wnt/β-catenin studies, APC-mutant colorectal models, and tankyrase biology. Combine reporter assays, protein-turnover measurements, and colony formation to distinguish pathway inhibition from nonspecific growth effects.
-
dhcr7 Knockout Grass Carp Shows GCRV Resistance
2026-08-25
A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and demonstrated an approximately 40% survival advantage after GCRV-II challenge. The work provides in vivo evidence that a cholesterol-biosynthesis enzyme can influence antiviral immunity without compromising growth or muscle morphology.
-
Bovine Liver Organoids Model Dairy Cow Fatty Liver
2026-08-24
Lei et al. developed a bovine liver organoid system that reproduces key features of fatty liver disease in high-yielding dairy cows, including triglyceride and cholesterol accumulation after fatty-acid exposure. The model also enabled preliminary evaluation of natural compounds and atorvastatin, offering a species-relevant platform for disease mechanism studies and therapeutic screening while reducing reliance on live-animal experiments.
-
STMN2 Loss in ALS: Translation and Stress Granules
2026-08-23
This study identifies TDP-43-independent mechanisms that rapidly deplete the neuronal protein STMN2 during cellular stress, linking proteasomal degradation, phosphorylation, translation repression, and stress granules. Its findings suggest that baseline STMN2 abundance and regional RNA compensation may influence neuronal vulnerability in amyotrophic lateral sclerosis (ALS), while providing a framework for longitudinal stress and survival experiments.
450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page